earnings
Strategic Logistics Expansion and CHOPS Device Drive Global Growth (TMDX Q1 2026 Earnings Call)
TransMedics initiated the fiscal year with strong momentum, delivering $174 million in total revenue while investing in active cooling technology and European logistics expansion to capture a broader transplant market.